2,5-Dimethoxy-4-hexylamphetamine

DOHx
Clinical data
Other names2,5-Dimethoxy-4-hexylamphetamine; 2,5-Dimethoxy-4-n-hexylamphetamine; 4-Hexyl-2,5-dimethoxyamphetamine; DOHx; DOHX; DOHE
Drug classSerotonin 5-HT2 receptor modulator; Serotonin receptor antagonist
ATC code
  • None
Identifiers
  • 1-(4-hexyl-2,5-dimethoxyphenyl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC17H29NO2
Molar mass279.424 g·mol−1
3D model (JSmol)
  • CCCCCCC1=CC(=C(C=C1OC)CC(C)N)OC
  • InChI=1S/C17H29NO2/c1-5-6-7-8-9-14-11-17(20-4)15(10-13(2)18)12-16(14)19-3/h11-13H,5-10,18H2,1-4H3
  • Key:NICYQFWHLYLNFE-UHFFFAOYSA-N

2,5-Dimethoxy-4-hexylamphetamine (DOHx or DOHE) is a non-hallucinogenic serotonin receptor modulator of the phenethylamine, amphetamine, and DOx families.

Pharmacology

Pharmacodynamics

DOHx has shown the highest affinity for the serotonin 5-HT2A and 5-HT2C receptors of any other assessed DOx drug in multiple studies. In one study, its affinities for the human serotonin 5-HT2 receptors were 0.1 nM for the 5-HT2A receptor, 30 nM for the 5-HT2B receptor, and 0.7 nM for 5-HT2C receptor. In the case of the serotonin 5-HT2A receptor, this was 6- to 14-fold higher than DOB, DOI, and DOC and was 9-fold higher than DOPR. In another study, DOHx showed 25-fold higher affinity for the serotonin 5-HT2A receptor than DOM or DOET, 23- to 28-fold higher affinity than DOPR and DOBU, and 2.8-fold higher affinity than DOAM. Conversely, it showed only slightly higher or roughly the same affinity for the receptor relative to DOCT (2.5 nM vs. 3.0 nM, respectively).

In contrast to many other DOx drugs, DOHx, as well as related drugs like DOCT, have been found to act as serotonin 5-HT2 receptor antagonists rather than as an agonists, and hence would not be expected to be serotonergic psychedelics. In accordance, DOHx, DOCT, and other related drugs do not produce DOM-like effects in rodent drug discrimination tests. DOHx has also been assessed and found to act as a silent antagonist of the serotonin 5-HT2B receptor (EmaxTooltip maximal efficacy = 0%).

Chemistry

DOHx is part of the series of 4-alkylated DOx drugs that includes DOM (methyl), DOET (ethyl), DOPR (propyl), DOBU (butyl), and DOAM (amyl/pentyl), with DOHx having a hexyl substitution and hence the longest alkyl chain of the preceding drugs. Following DOHx in the series are DOHP (heptyl) and then DOCT (octyl).

Synthesis

The chemical synthesis of DOHx has been described.

History

DOHx was first described in the scientific literature by Richard Glennon and colleagues by 1989.

Society and culture

Canada

DOHx is a controlled substance in Canada under phenethylamine blanket-ban language.

See also